AstraZeneca

Age cap in Oxford vaccine trials casts doubt over results
British pharmaceutical company AstraZeneca
In Brief

Age cap in Oxford vaccine trials casts doubt over results

AstraZeneca failed to disclose that under-55s made up test group in which jab was most effective
26 Nov 2020
Inside the ‘ten-month marathon’ to produce Oxford vaccine
Vials of the Oxford Covid-19 vaccine in front of a sign for Oxford University
In Depth

Inside the ‘ten-month marathon’ to produce Oxford vaccine

Team behind university’s Covid jab admit the 90% effective dosage was discovered by mistake
24 Nov 2020
Will the Oxford Covid vaccine be the true game-changer?
An Oxford scientist working on vaccine development.
In Depth

Will the Oxford Covid vaccine be the true game-changer?

Latest trial results show the university’s jab is up to 90% effective
23 Nov 2020
Oxford Covid-19 vaccine paused over ‘spinal disease’ fears
Vaccine
In Brief

Oxford Covid-19 vaccine paused over ‘spinal disease’ fears

Leaked report says volunteer in UK was left unable to walk after receiving two doses
21 Sep 2020
Oxford scientists: ‘what we’re doing to get a Covid vaccine’
Oxford vaccine
In Depth

Oxford scientists: ‘what we’re doing to get a Covid vaccine’

Researchers working to develop the world’s first Covid-19 vaccine explain how it is being done
10 Sep 2020
Reaction: hopes raised in Oxford vaccine trial - what next?
Coronavirus vaccine
In Depth

Reaction: hopes raised in Oxford vaccine trial - what next?

Results of first human tests fuel hopes that jab may be rolled out by Christmas
21 Jul 2020
Reaction: Covid vaccine hopes raised by Oxford trial results
Coronavirus vaccine
In Depth

Reaction: Covid vaccine hopes raised by Oxford trial results

Scientists from university-led team say their jab may offer ‘double defence’ against coronavirus
16 Jul 2020

An open mind on the issues that matter

The Week magazine is simple and clever. Subscribe today and your first 6 issues are completely free.
AstraZeneca rejects 'final' £69bn offer from Pfizer
British pharmaceutical firm AstraZeneca
In Brief

AstraZeneca rejects 'final' £69bn offer from Pfizer

AstraZeneca claims £55-per-share bid undervalues the company and carries a 'big execution risk'
19 May 2014
State must intervene in the fight for AstraZeneca
AstraZeneca
In Depth

State must intervene in the fight for AstraZeneca

Cosseting national champions isn’t the British way. But is it time to make an exception
2 May 2014
Free 6 issue trial then continue to